Clinical Trial Update: Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term safety and efficacy of MND-2119 in patients with hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• MND-2119

Snippet

Sponsor: Mochida Pharmaceutical Company, Ltd. | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED